Market Tracker

10/30 7:58am ET

Orexigen Therapeutics Inc (NASDAQ:OREX)

4.06
Data as of Oct 29
 -0.13 / -3.10%
Today’s Change
3.11
Today|||52-Week Range
7.82
-27.89%
Year-to-Date

Today’s Trading

Previous close4.19
Today’s open4.20
Day’s range-- - --
Volume2,019,025
Average volume (3 months)4,190,211
Market cap$497.5M
Dividend yield--
Data as of 10/29/2014

Growth & Valuation

Earnings growth (last year)+37.01%
Earnings growth (this year)+92.50%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)0.00%
P/E ratioNM
Price/Sales158.47
Price/Book10.18

Competitors

 Today’s
change
Today’s
% change
ARRYArray Biopharma Inc-0.03-0.78%
SPPISpectrum Pharmaceuti...-0.15-1.96%
IGIGI Laboratories Inc+0.33+3.58%
FLMLFlamel Technologies ...+0.15+1.16%
Data as of 10/29/2014

Financials

Next reporting dateNovember 5, 2014
EPS forecast (this quarter)-$0.20
Annual revenue (last year)$3.4M
Annual profit (last year)-$77.7M
Net profit margin-2,265.78%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael A. Narachi
CFO, Treasurer &
Chief Business Officer
Joseph P. Hagan
Corporate headquarters
La Jolla, California

Forecasts